FdaApplication
NDA 209279
Identifiers
- fda_app_no: NDA209279
Properties
| Property | Value |
|---|---|
| applicant_name | ACTELION PHARMACEUTICALS US INC |
| application_type | NDA |
| approval_date | 2017-09-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRACLEER | BOSENTAN | 32MG | TABLET, FOR SUSPENSION;ORAL |
1 product